Monitoring of human papillomavirus vaccination
β Scribed by J. Dillner; M. Arbyn; E. Unger; L. Dillner
- Book ID
- 108701302
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 162 KB
- Volume
- 163
- Category
- Article
- ISSN
- 0009-9104
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
TABLE 1 Results From an Ad Hoc Meeting Conducted by the Pan American Health Organization on Important Biologic Endpoints for Human Papillomavirus Vaccine Surveillance Endpoints for HPV Surveillance and Measurement Indicators Endpoint Measurement Indicator Genital HPV infections Changes in prevalence
## Abstract A wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intraβepithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention
There is justifiable excitement about the recent introduction of prophylactic vaccines against human papillomavirus (HPV) types 16 (HPV-16) and HPV-18. Preventing these infections theoretically could avert approximately 70% of cervical cancer cases worldwide. In the U.S., numerous influential advoca